Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer

類似資料

• Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
  著者:: Puri Raj K, 等
  出版事項: (2011-04-01)
• Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
  著者:: Fujisawa, Toshio, 等
  出版事項: (2013)
• Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients
  著者:: Fujisawa, Toshio, 等
  出版事項: (2015)
• Interleukin 13 receptor alpha 2 directed immunotherapy targets hepatic fibrosis and tumorigenesis induced by choline deficient diet in an in vivo mouse model of nonalcoholic steatohepatitis
  著者:: Fujisawa, Toshio, 等
  出版事項: (2014)
• A Novel Combination Immunotherapy for Cancer by IL-13Rα2–Targeted DNA Vaccine and Immunotoxin in Murine Tumor Models
  著者:: Nakashima, Hideyuki, 等
  出版事項: (2011)